{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T20:28:47Z","timestamp":1793651327486,"version":"4.5.1"},"reference-count":54,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology\/Oncology Clinics of North America"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.hoc.2026.08.002","type":"journal-article","created":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T11:34:30Z","timestamp":1790595270000},"page":"1089-1104","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Microbial Signals in Gliomas"],"prefix":"10.1016","volume":"40","author":[{"given":"Oscar","family":"Alcantar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Dono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angel","family":"Bueno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshua","family":"Esquenazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.hoc.2026.08.002_bib1","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1001\/jama.2023.0023","article-title":"Glioblastoma and other primary brain malignancies in adults: a review","volume":"329","author":"Schaff","year":"2023","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.hoc.2026.08.002_bib2","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S1474-4422(19)30356-4","article-title":"The gut microbiome in neurological disorders","volume":"19","author":"Cryan","year":"2020","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.hoc.2026.08.002_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1739329","article-title":"The gut microbiota influences neurodegenerative diseases through the gut-brain axis: molecular mechanisms and effects on immune function","volume":"16","author":"Yang","year":"2026","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.hoc.2026.08.002_bib4","doi-asserted-by":"crossref","first-page":"e77","DOI":"10.1016\/S1470-2045(18)30952-5","article-title":"Modulating the microbiome to improve therapeutic response in cancer","volume":"20","author":"McQuade","year":"2019","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.hoc.2026.08.002_bib5","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-77919-w","article-title":"Glioma and temozolomide induced alterations in gut microbiome","volume":"10","author":"Patrizz","year":"2020","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.hoc.2026.08.002_bib6","doi-asserted-by":"crossref","DOI":"10.2217\/cns-2020-0007","article-title":"Glioma induced alterations in fecal short-chain fatty acids and neurotransmitters","volume":"9","author":"Dono","year":"2020","journal-title":"CNS Oncol"},{"issue":"5","key":"10.1016\/j.hoc.2026.08.002_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0304403","article-title":"Discussion on the relationship between gut microbiota and glioma through Mendelian randomization test based on the brain gut axis","volume":"19","author":"Cui","year":"2024","journal-title":"PLoS One"},{"key":"10.1016\/j.hoc.2026.08.002_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112881","article-title":"Short-chain fatty acids reverses gut microbiota dysbiosis-promoted progression of glioblastoma by up-regulating M1 polarization in the tumor microenvironment","volume":"141","author":"Zhou","year":"2024","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.hoc.2026.08.002_bib9","article-title":"Gut microbiome functional pathways outperform taxonomic profiles in predicting immune checkpoint inhibitor response in non-small cell lung cancer: an interpretable machine learning approach with SHAP","volume":"17","author":"Wei","year":"2026","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.hoc.2026.08.002_bib10","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00338-20","article-title":"A comprehensive review on the role of the gut microbiome in human neurological disorders","volume":"35","author":"Sorboni","year":"2022","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.hoc.2026.08.002_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2021.107988","article-title":"Gut dysbiosis, defective autophagy and altered immune responses in neurodegenerative diseases: tales of a vicious cycle","volume":"231","author":"Chidambaram","year":"2022","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.hoc.2026.08.002_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2022.836605","article-title":"Mechanistic insights into gut microbiome dysbiosis-mediated neuroimmune dysregulation and protein misfolding and clearance in the pathogenesis of chronic neurodegenerative disorders","volume":"16","author":"Padhi","year":"2022","journal-title":"Front Neurosci"},{"key":"10.1016\/j.hoc.2026.08.002_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuroscience.2025.07.003","article-title":"Parkinson\u2019s disease and the gut microbiota connection: unveiling dysbiosis and exploring therapeutic Horizons","volume":"581","author":"Yadav","year":"2025","journal-title":"Neuroscience"},{"issue":"72","key":"10.1016\/j.hoc.2026.08.002_bib14","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1093\/jncimonographs\/lgaf040","article-title":"Oncogenic infections: targets highly amenable to cancer prevention","volume":"2026","author":"Alberts","year":"2026","journal-title":"JNCI Monogr"},{"issue":"12","key":"10.1016\/j.hoc.2026.08.002_bib15","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1001\/jamaoncol.2023.4273","article-title":"Cancers attributable to infections in the US in 2017: a meta-analysis","volume":"9","author":"Volesky-Avellaneda","year":"2023","journal-title":"JAMA Oncol"},{"issue":"7","key":"10.1016\/j.hoc.2026.08.002_bib16","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1001\/jamaoncol.2022.0494","article-title":"The potential of the gut microbiome to reshape the cancer therapy paradigm: a review","volume":"8","author":"Liu","year":"2022","journal-title":"JAMA Oncol"},{"issue":"24","key":"10.1016\/j.hoc.2026.08.002_bib17","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1001\/jama.2025.2191","article-title":"The microbiome and cancer: a translational science review","volume":"333","author":"Fernandez","year":"2025","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.hoc.2026.08.002_bib18","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1053\/j.gastro.2022.10.018","article-title":"Gut microbiota modulation of efficacy and toxicity of cancer chemotherapy and immunotherapy","volume":"164","author":"Chrysostomou","year":"2023","journal-title":"Gastroenterology"},{"key":"10.1016\/j.hoc.2026.08.002_bib19","article-title":"Navigating the gut\u2013metabolite\u2013immune axis: enhancing efficacy and mitigating toxicity of immune checkpoint inhibitors","volume":"17","author":"Zhang","year":"2026","journal-title":"Front Immunol"},{"key":"10.1016\/j.hoc.2026.08.002_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2026.1883259","article-title":"Functional convergence amid taxonomic variability in gut microbiome\u2013immune checkpoint inhibitor research: a bibliometric and mechanistic synthesis","volume":"17","author":"Alanazi","year":"2026","journal-title":"Front Immunol"},{"issue":"6529","key":"10.1016\/j.hoc.2026.08.002_bib21","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1126\/science.abb5920","article-title":"Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients","volume":"371","author":"Baruch","year":"2021","journal-title":"Science."},{"issue":"6529","key":"10.1016\/j.hoc.2026.08.002_bib22","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1126\/science.abf3363","article-title":"Fecal microbiota transplant overcomes resistance to anti\u2013PD-1 therapy in melanoma patients","volume":"371","author":"Davar","year":"2021","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.hoc.2026.08.002_bib23","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1038\/s41591-025-04186-5","article-title":"Fecal microbiota transplantation plus immunotherapy in non-small cell lung cancer and melanoma: the phase 2 FMT-LUMINate trial","volume":"32","author":"Duttagupta","year":"2026","journal-title":"Nat Med"},{"issue":"7","key":"10.1016\/j.hoc.2026.08.002_bib24","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2026-015122","article-title":"Safety and efficacy of fecal microbiota transplantation in solid cancers resistant to immune checkpoint inhibitors: results of the MITRIC trial","volume":"14","author":"Ullern","year":"2026","journal-title":"J Immunother Cancer"},{"issue":"8","key":"10.1016\/j.hoc.2026.08.002_bib25","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1038\/s41591-023-02453-x","article-title":"Fecal microbiota transplantation plus anti-PD-1 immunotherapy in advanced melanoma: a phase I trial","volume":"29","author":"Routy","year":"2023","journal-title":"Nat Med"},{"issue":"S1","key":"10.1016\/j.hoc.2026.08.002_bib26","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/cns.14081","article-title":"Gut microbiota in brain tumors: an emerging crucial player","volume":"29","author":"Lin","year":"2023","journal-title":"CNS Neurosci Ther"},{"key":"10.1016\/j.hoc.2026.08.002_bib27","article-title":"Gut microbiome alterations affect glioma development and Foxp3 expression in tumor microenvironment in mice","volume":"12","author":"Fan","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.hoc.2026.08.002_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2024.106888","article-title":"Dysbiosis of the gut microbiota in glioblastoma patients and potential biomarkers for risk assessment","volume":"195","author":"Jiang","year":"2024","journal-title":"Microb Pathog"},{"key":"10.1016\/j.hoc.2026.08.002_bib29","article-title":"Crosstalk between the gut and brain: importance of the fecal microbiota in patient with brain tumors","volume":"12","author":"Li","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"10.1016\/j.hoc.2026.08.002_bib30","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1007\/s10143-026-04205-0","article-title":"Gut microbiota modulation as an adjuvant therapy to improve treatment response and survival in brain tumor patients: a systematic review","volume":"49","author":"Balafif","year":"2026","journal-title":"Neurosurg Rev"},{"issue":"9","key":"10.1016\/j.hoc.2026.08.002_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e30494","article-title":"The gut-brain-axis: a positive relationship between gut microbial dysbiosis and glioblastoma brain tumour","volume":"10","author":"Ishaq","year":"2024","journal-title":"Heliyon"},{"issue":"5","key":"10.1016\/j.hoc.2026.08.002_bib32","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/eji.201948354","article-title":"Gut microbiota alterations affect glioma growth and innate immune cells involved in tumor immunosurveillance in mice","volume":"50","author":"D\u2019Alessandro","year":"2020","journal-title":"Eur J Immunol"},{"issue":"1","key":"10.1016\/j.hoc.2026.08.002_bib33","article-title":"Human gut microbial communities dictate efficacy of anti-PD-1 therapy in a humanized microbiome mouse model of glioma","volume":"3","author":"Dees","year":"2021","journal-title":"Neuro-Oncol Adv"},{"issue":"1","key":"10.1016\/j.hoc.2026.08.002_bib34","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3390\/cancers15010217","article-title":"Sodium propionate contributes to tumor cell growth inhibition through PPAR-\u03b3 signaling","volume":"15","author":"Filippone","year":"2022","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.hoc.2026.08.002_bib35","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1186\/s12864-023-09885-2","article-title":"Investigating the causal impact of gut microbiota on glioblastoma: a bidirectional Mendelian randomization study","volume":"24","author":"Zeng","year":"2023","journal-title":"BMC Genom"},{"key":"10.1016\/j.hoc.2026.08.002_bib36","article-title":"Dissecting causal relationships between gut microbiota, blood metabolites, and glioblastoma multiforme: a two-sample Mendelian randomization study","volume":"15","author":"Chen","year":"2024","journal-title":"Front Microbiol"},{"issue":"8","key":"10.1016\/j.hoc.2026.08.002_bib37","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20241135","article-title":"Gut dysbiosis from high-salt diet promotes glioma via propionate-mediated TGF-\u03b2 activation","volume":"222","author":"Kim","year":"2025","journal-title":"J Exp Med"},{"issue":"11","key":"10.1016\/j.hoc.2026.08.002_bib38","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1016\/j.ccell.2025.09.002","article-title":"Ketogenic diet inhibits glioma progression by promoting gut microbiota-derived butyrate production","volume":"43","author":"Chen","year":"2025","journal-title":"Cancer Cell"},{"key":"10.1016\/j.hoc.2026.08.002_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2025.152216","article-title":"Molecular basis of the therapeutic effect of butyrate in glioblastoma revealed by in vitro and in silico approach","volume":"777","author":"Ashwini","year":"2025","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"10.1016\/j.hoc.2026.08.002_bib40","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s10143-025-03788-4","article-title":"Unveiling gut microbiome divergence in sellar-parasellar masses and brain tumors: a link beyond the skull","volume":"48","author":"Gundogdu","year":"2025","journal-title":"Neurosurg Rev"},{"key":"10.1016\/j.hoc.2026.08.002_bib41","article-title":"Gut microbiota induces immune-related alterations in gene expression, RNA methylation, and metabolism in glioblastoma revealed by single-cell and spatial multi-omics","volume":"17","author":"Chen","year":"2026","journal-title":"Front Immunol"},{"key":"10.1016\/j.hoc.2026.08.002_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.clon.2026.104209","article-title":"Broad-spectrum antibiotics are associated with worse survival after radical treatment for glioblastoma multiforme: a multicentre study","volume":"56","author":"Main","year":"2026","journal-title":"Clin Oncol"},{"issue":"1","key":"10.1016\/j.hoc.2026.08.002_bib43","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2026.2623349","article-title":"Muribaculum intestinale negatively impacts glioma growth in mice through the toll-like receptor 2","volume":"18","author":"Marrocco","year":"2026","journal-title":"Gut Microbes"},{"issue":"11","key":"10.1016\/j.hoc.2026.08.002_bib44","doi-asserted-by":"crossref","first-page":"3675","DOI":"10.1038\/s41591-025-03957-4","article-title":"Microbial signals in primary and metastatic brain tumors","volume":"31","author":"Morad","year":"2025","journal-title":"Nat Med"},{"issue":"11","key":"10.1016\/j.hoc.2026.08.002_bib45","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1038\/s43018-025-01073-3","article-title":"Characterization of the tumor microbiome of brain metastases and glioblastoma reveals tumor-type-specific and location-specific microbial signatures","volume":"6","author":"Gigi","year":"2025","journal-title":"Nat Cancer"},{"key":"10.1016\/j.hoc.2026.08.002_bib46","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.746568","article-title":"Association between oral microbiota and human brain glioma grade: a case-control study","volume":"12","author":"Wen","year":"2021","journal-title":"Front Microbiol"},{"key":"10.1016\/j.hoc.2026.08.002_bib47","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2024.1344284","article-title":"Multi-omics-based investigation of Bifidobacterium\u2019s inhibitory effect on glioma: regulation of tumor and gut microbiota, and MEK\/ERK cascade","volume":"15","author":"Fan","year":"2024","journal-title":"Front Microbiol"},{"issue":"3","key":"10.1016\/j.hoc.2026.08.002_bib48","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/s41419-024-06578-w","article-title":"Antibiotics treatment promotes vasculogenesis in the brain of glioma-bearing mice","volume":"15","author":"Rosito","year":"2024","journal-title":"Cell Death Dis"},{"issue":"1","key":"10.1016\/j.hoc.2026.08.002_bib49","doi-asserted-by":"crossref","first-page":"3950","DOI":"10.1038\/s41467-025-56930-7","article-title":"Improved overall survival in an anti-PD-L1 treated cohort of newly diagnosed glioblastoma patients is associated with distinct immune, mutation, and gut microbiome features: a single arm prospective phase I\/II trial","volume":"16","author":"Weathers","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.hoc.2026.08.002_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116420","article-title":"Exploring the gut microbiota and its potential as a biomarker in gliomas","volume":"173","author":"Aljarrah","year":"2024","journal-title":"Biomed Pharmacother"},{"issue":"3","key":"10.1016\/j.hoc.2026.08.002_bib51","doi-asserted-by":"crossref","DOI":"10.1111\/1751-7915.70336","article-title":"Relationship between gut microbiota and cancer neuro-immunity","volume":"19","author":"Wang","year":"2026","journal-title":"Microb Biotechnol"},{"key":"10.1016\/j.hoc.2026.08.002_bib52","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.2147\/DDDT.S298261","article-title":"Temozolomide-induced changes in gut microbial composition in a mouse model of brain glioma","volume":"15","author":"Li","year":"2021","journal-title":"Drug Des Dev Ther"},{"issue":"8","key":"10.1016\/j.hoc.2026.08.002_bib53","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/S1474-4422(26)00193-6","article-title":"The role of the gut microbiome in mediating neuroinflammation in immune-based neurological disorders","volume":"25","author":"Steriade","year":"2026","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.hoc.2026.08.002_bib54","article-title":"Role of gut microbiota in regulating immune checkpoint inhibitor therapy for glioblastoma","volume":"15","author":"Zhang","year":"2024","journal-title":"Front Immunol"}],"container-title":["Hematology\/Oncology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858826001036?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858826001036?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T19:55:41Z","timestamp":1793649341000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889858826001036"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":54,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["S0889858826001036"],"URL":"https:\/\/doi.org\/10.1016\/j.hoc.2026.08.002","relation":{},"ISSN":["0889-8588"],"issn-type":[{"value":"0889-8588","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Microbial Signals in Gliomas","name":"articletitle","label":"Article Title"},{"value":"Hematology\/Oncology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hoc.2026.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}